Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dennis Ausiello Insider Profile
4 Followers
Dennis Ausiello, Director at Alnylam Pharma, holds 3.64K shares in Alnylam Pharma (Ticker: ALNY), holds ― shares in Seres Therapeutics (Ticker: MCRB), holds ― shares in Rani Therapeutics Holdings (Ticker: RANI).
Dennis Ausiello has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dennis Ausiello holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Dennis Ausiello
Dennis Ausiello's Trading History
Alnylam Pharma
Feb 27, 2023
Director
Uninformative Buy
―
$553.73K
Seres Therapeutics
―
Director
―
―
Rani Therapeutics Holdings
―
Director
―
―
Pfizer
Oct 19, 2009
Director
Uninformative Buy
―
$66.77K
List of latest transactions for each holding click on a transaction to see Dennis Ausiello's performance on stock
You May Also Like
Dennis Ausiello insider profile FAQ
What is the percentage of profitable transactions made by Dennis Ausiello?
The percentage of profitable transactions made by Dennis Ausiello is ―.
What is the average return per transaction made by Dennis Ausiello?
The average return per transaction made by Dennis Ausiello is ―.
What stocks does Dennis Ausiello hold?
Dennis Ausiello holds: ALNY, MCRB, RANI, PFE stocks.
What was Dennis Ausiello’s latest transaction?
Dennis Ausiello latest transaction was an Uninformative Buy of ―.
What was Dennis Ausiello's most profitable transaction?
Dennis Ausiello’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Dennis Ausiello's role in Alnylam Pharma?
Dennis Ausiello's role in Alnylam Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.